Role of Imaging and AI in the Evaluation of COVID-19 Infection: A Comprehensive Survey.

Coronavirus disease 2019 (COVID-19) is a respiratory illness that started and rapidly became the pandemic of the century, as the number of people infected with it globally exceeded 253.4 million. Since the beginning of the pandemic of COVID-19, over two years have passed. During this hard period, several defies have been coped by the scientific society to know this novel disease, evaluate it, and treat affected patients. All these efforts are done to push back the spread of the virus. This article provides a comprehensive review to learn about the COVID-19 virus and its entry mechanism, its main repercussions on many organs and tissues of the body, identify its symptoms in the short and long terms, in addition to recognize the role of diagnosis imaging in COVID-19. Principally, the quick evolution of active vaccines act an exceptional accomplishment where leaded to decrease rate of death worldwide. However, some hurdels still have to be overcome. Many proof referrers that infection with CoV-19 causes neurological dis function in a substantial ratio of influenced patients, where these symptoms appear severely during the infection and still less is known about the potential long term consequences for the brain, where Loss of smell is a neurological sign and rudimentary symptom of COVID-19. Hence, we review the causes of olfactory bulb dysfunction and Anosmia associated with COVID-19, the latest appropriate therapeutic strategies for the COVID-19 treatment (e.g., the ACE2 strategy and the Ang II receptor), and the tests through the follow-up phases. Additionally, we discuss the long-term complications of the virus and thus the possibility of improving therapeutic strategies. Moreover, the main steps of artificial intelligence that have been used to foretell and early diagnose COVID-19 are presented, where Artificial intelligence, especially machine learning is emerging as an effective approach for diagnostic image analysis with performance in the discriminate diagnosis of injuries of COVID-19 on multiple organs, comparable to that of human practitioners. The followed methodology to prepare the current survey is to search the related work concerning the mentioned topic from different journals, such as Springer, Wiley, and Elsevier. Additionally, different studies have been compared, the results are collected and then reported as shown. The articles are selected based on the year (i.e., the last three years). Also, different keywords were checked (e.g., COVID-19, COVID-19 Treatment, COVID-19 Symptoms, and COVID-19 and Anosmia).

A complete framework for accurate recognition and prognosis of COVID-19 patients based on deep transfer learning and feature classification approach.

The sudden appearance of COVID-19 has put the world in a serious situation. Due to the rapid spread of the virus and the increase in the number of infected patients and deaths, COVID-19 was declared a pandemic. This pandemic has its destructive effect not only on humans but also on the economy. Despite the development and availability of different vaccines for COVID-19, scientists still warn the citizens of new severe waves of the virus, and as a result, fast diagnosis of COVID-19 is a critical issue. Chest imaging proved to be a powerful tool in the early detection of COVID-19. This study introduces an entire framework for the early detection and early prognosis of COVID-19 severity in the diagnosed patients using laboratory test results. It consists of two phases (1) Early Diagnostic Phase (EDP) and (2) Early Prognostic Phase (EPP). In EDP, COVID-19 patients are diagnosed using CT chest images. In the current study, 5, 159 COVID-19 and 10, 376 normal computed tomography (CT) images of Egyptians were used as a dataset to train 7 different convolutional neural networks using transfer learning. Data augmentation normal techniques and generative adversarial networks (GANs), CycleGAN and CCGAN, were used to increase the images in the dataset to avoid overfitting issues. 28 experiments were applied and multiple performance metrics were captured. Classification with no augmentation yielded 99.61 % accuracy by EfficientNetB7 architecture. By applying CycleGAN and CC-GAN Augmentation, the maximum reported accuracies were 99.57 % and 99.14 % by MobileNetV1 and VGG-16 architectures respectively. In EPP, the prognosis of the severity of COVID-19 in patients is early determined using laboratory test results. In this study, 25 different classification techniques were applied and from the different results, the highest accuracies were 98.70 % and 97.40 % reported by the Ensemble Bagged Trees and Tree (Fine, Medium, and Coarse) techniques respectively.

CovH2SD: A COVID-19 detection approach based on Harris Hawks Optimization and stacked deep learning.

Starting from Wuhan in China at the end of 2019, coronavirus disease (COVID-19) has propagated fast all over the world, affecting the lives of billions of people and increasing the mortality rate worldwide in few months. The golden treatment against the invasive spread of COVID-19 is done by identifying and isolating the infected patients, and as a result, fast diagnosis of COVID-19 is a critical issue. The common laboratory test for confirming the infection of COVID-19 is Reverse Transcription Polymerase Chain Reaction (RT-PCR). However, these tests suffer from some problems in time, accuracy, and availability. Chest images have proven to be a powerful tool in the early detection of COVID-19. In the current study, a hybrid learning and optimization approach named CovH2SD is proposed for the COVID-19 detection from the Chest Computed Tomography (CT) images. CovH2SD uses deep learning and pre-trained models to extract the features from the CT images and learn from them. It uses Harris Hawks Optimization (HHO) algorithm to optimize the hyperparameters. Transfer learning is applied using nine pre-trained convolutional neural networks (i.e. ResNet50, ResNet101, VGG16, VGG19, Xception, MobileNetV1, MobileNetV2, DenseNet121, and DenseNet169). Fast Classification Stage (FCS) and Compact Stacking Stage (CSS) are suggested to stack the best models into a single one. Nine experiments are applied and results are reported based on the Loss, Accuracy, Precision, Recall, F1-Score, and Area Under Curve (AUC) performance metrics. The comparison between combinations is applied using the Weighted Sum Method (WSM). Six experiments report a WSM value above 96.5%. The top WSM and accuracy reported values are 99.31% and 99.33% respectively which are higher than the eleven compared state-of-the-art studies.

Hybrid COVID-19 segmentation and recognition framework (HMB-HCF) using deep learning and genetic algorithms.

COVID-19 (Coronavirus) went through a rapid escalation until it became a pandemic disease. The normal and manual medical infection discovery may take few days and therefore computer science engineers can share in the development of the automatic diagnosis for fast detection of that disease. The study suggests a hybrid COVID-19 framework (named HMB-HCF) based on deep learning (DL), genetic algorithm (GA), weighted sum (WS), and majority voting principles in nine phases. Its segmentation phase suggests a lung segmentation algorithm using X-Ray images (named HMB-LSAXI) for extracting lungs. Its classification phase is built from a hybrid convolutional neural network (CNN) architecture using an abstractly-designed CNN (named HMB1-COVID19) and transfer learning (TL) pre-trained models (VGG16, VGG19, ResNet50, ResNet101, Xception, DenseNet121, DenseNet169, MobileNet, and MobileNetV2). The hybrid CNN architecture is used for learning, classification, and parameters optimization while GA is used to optimize the hyperparameters. This hybrid working mechanism is combined in an overall algorithm named HMB-DLGA. The study experiments implemented the WS approach to evaluate the models' performance using the loss, accuracy, F1-score, precision, recall, and area under curve (AUC) metrics with different pre-defined ratios. A collected, combined, and unified X-Ray dataset from 8 different public datasets was used alongside the regularization, dropout, and data augmentation techniques to limit the overall overfitting. The applied experiments reported state-of-the-art metrics. VGG16 reported 100% WS metric (i.e., 0.0097, 99.78%, 0.9984, 99.89%, 99.78%, and 0.9996 for the loss, accuracy, F1, precision, recall, and AUC respectively) concerning the highest WS. It also reported a 99.92% WS metric (i.e., 0.0099, 99.84%, 0.9984, 99.84%, 99.84%, and 0.9996 for the loss, accuracy, F1, precision, recall, and AUC respectively) concerning the last reported WS result. HMB-HCF was validated on 13 different public datasets to verify its generalization. The best-achieved metrics were compared with 13 related studies. These extensive experiments' target was the applicability verification and generalization.